ZBZhang Baojuan

Zhang Baojuan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhang Baojuan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Chinese Guideline for the Diagnosis and Treatment of Chronic LOW Back Pain (2024 Edition)

    by Zhi-Xiang Cheng, Xian-Guo Liu, Yan Lu, Ke Ma, Dong Huang, Qing Liu, Xiao-Qiu Yang, Li-Juan Lu, Tang-Hua Liu, Lin Wang, et al.

    Background: Low back pain (LBP) is the leading cause of disability worldwide, severely impairing patients' quality of life, consuming substantial healthcare resources, and increasing medical costs while reducing productivity. Low back pain has become the leading cause of disability worldwide and a major global public health issue. Objective: To enhance the ability of diagnosis and treatment for LBP to meet the needs of clinical diagnosis and treatment. Main ideas: Based on high quality evidence based medical research on the diagnosis and treatment of LBP published domestically and internationally between January 2010 and December 2023, the expert group of the Pain Disease Diagnosis and Treatment Special Capacity Enhancement Project of the National Health Commission of China's Capacity Building and Continuing Education Centerhas formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of LBP. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common chronic specific low back pain (cSLBP) and chronic non-specific low back pain (cNSLBP). Conclusion: LBP is characterized by high prevalence, significant disability rates, and frequent recurrence, imposing substantial burdens on individuals, families, and society. For patients, improving understanding of cLBP, practicing effective self-management, and actively cooperating with treatment are crucial for disease prognosis. Healthcare providers must enhance patient education and clinical competencies while strictly adhering to diagnostic and therapeutic guidelines for comprehensive cLBP management. Policymakers and academic organizations should focus on developing evidence-based clinical guidelines, strengthening healthcare system oversight, and promoting widespread implementation of standardized cLBP care protocols.

  • Open Access

    A Chinese Guideline for the Diagnosis and Treatment of Neuropathic Pain

    by Cheng Zhixiang, Lu Yan, Liu Xianguo, Xia Lingjie, Huang Dong, Song Tao, Liang Lishuang, Zhang Ying, Liu Tanghua, Wang Lin, et al.

    Background : Neuropathic pain refers to pain caused by injury or disease affecting the somatosensory nervous system, which is a common and frequently occurring disease in clinical practice, and seriously affects patients' quality of life. However, the treatment of neuropathic pain is a clinical challenge. Objective : To standardize neuropathic pain management, the Pain Medicine Branch of China Association of Health Care for the Elderly convened an expert panel to develop the guideline. Main ideas : Based on high quality evidence-based medical research on the diagnosis and treatment of neuropathic pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of neuropathic pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common peripheral neuropathic pain and central neuropathic pain. Chinese traditional medicine also plays an important role in the treatment of neuropathic pain, so this guide also provides Chinese traditional medicine drugs and treatment recommendations. Conclusion : The Chinese pain community has proposed the principle of "treatment forward, early intervention, prevention of sensitization, and prevention and treatment of chronic pain", which has played a positive role in improving the clinical diagnosis and treatment level of neuropathic pain.


  • Open Access

    A Chinese Guideline for the Diagnosis and Treatment of Chronic Cancer-related Pain

    by Cheng Zhixiang, Ma Ke, Wang Jianxiu, Wang Dequan, Shi Cunwei, Liu Jinfeng, Liu Haipeng, Song Tao, Zhang Baojuan, Lin Xuewu, et al.

    Background: Chronic cancer-related pain can seriously damage physical and mental health of cancer patients. Eliminating cancer pain is basic right of cancer patients, controlling and eliminating cancer pain is the responsibility of medical staff. Objective: To further enhance the diagnosis and treatment capabilities for chronic cancer-related pain management, the Chinese Clinical Guideline for Chronic Cancer-Related Pain convened an expert panel to develop the guideline. Main ideas: Based on high quality evidence of medical researches on the diagnosis and treatment of chronic cancer-related pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of chronic cancer-related pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of chronic cancer-related pain. This guideline gives treatment recommendations for different types of chronic cancer-related pain in International Classification of Diseases-11, as well as for breakthrough cancer pain. Conclusion: Although there are many treatments to relieve chronic cancer-related pain, it is still a global medical challenge. According to the characteristics of cancer-related pain, stepped and personalized treatment is the key to relieve pain.